ArticleCell proliferation2023

Activation of ERK1/2 by MOS and TPL2 leads to dasatinib resistance in chronic myeloid leukaemia cells.

Masanobu Tsubaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.